The Expression of LDL-R in CD8+ T Cells Serves as an Early Assessment Parameter for the Production of TCR-T Cells
Copyright © 2023, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved..
BACKGROUND/AIM: The quantity and the phenotypes of desired T cell receptor engineered T (TCR-T) cells in the final cell product determine their in vivo anti-tumor efficacy. Optimization of key steps in the TCR-T cell production process, such as T cell activation, has been shown to improve cell quality.
MATERIALS AND METHODS: Using a modified TCR (mTCR) derived from mice transducing PBMCs, we assessed the proportions of low-density lipoprotein receptor (LDL-R) and mTCR expressing cells under the various activation conditions of CD3/CD28-Dynabeads or OKT3 via flow cytometry.
RESULTS: We demonstrate that the proportion of T cells expressing LDL-R post activation is positively correlated with the percentage of mTCR+CD8+ T cells with their less differentiated subtypes in the final product. In addition, we show that shifting the CD3/CD28-Dynabeads activation duration from a typical 48 h to 24 h can significantly increase the production of the desired mTCR+CD8+ T cells. Importantly, the percentages of TCR-T cells with less-differentiated phenotypes, namely mTCR central memory T cells (TCM), were found to be preserved with markedly higher efficiency when T cell activation was optimized.
CONCLUSION: Our findings suggest that the proportion of LDL-R+ T cells may serve as an early assessment parameter for evaluating TCR-T cell quality, possibly facilitating the functional and economical improvement of current adoptive therapy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
---|---|
Enthalten in: |
In vivo (Athens, Greece) - 37(2023), 6 vom: 31. Nov., Seite 2480-2489 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Y I [VerfasserIn] |
---|
Links: |
---|
Themen: |
CD28 Antigens |
---|
Anmerkungen: |
Date Completed 01.11.2023 Date Revised 04.11.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.21873/invivo.13355 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363976329 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM363976329 | ||
003 | DE-627 | ||
005 | 20231226094501.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.21873/invivo.13355 |2 doi | |
028 | 5 | 2 | |a pubmed24n1213.xml |
035 | |a (DE-627)NLM363976329 | ||
035 | |a (NLM)37905663 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Y I |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Expression of LDL-R in CD8+ T Cells Serves as an Early Assessment Parameter for the Production of TCR-T Cells |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.11.2023 | ||
500 | |a Date Revised 04.11.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. | ||
520 | |a BACKGROUND/AIM: The quantity and the phenotypes of desired T cell receptor engineered T (TCR-T) cells in the final cell product determine their in vivo anti-tumor efficacy. Optimization of key steps in the TCR-T cell production process, such as T cell activation, has been shown to improve cell quality | ||
520 | |a MATERIALS AND METHODS: Using a modified TCR (mTCR) derived from mice transducing PBMCs, we assessed the proportions of low-density lipoprotein receptor (LDL-R) and mTCR expressing cells under the various activation conditions of CD3/CD28-Dynabeads or OKT3 via flow cytometry | ||
520 | |a RESULTS: We demonstrate that the proportion of T cells expressing LDL-R post activation is positively correlated with the percentage of mTCR+CD8+ T cells with their less differentiated subtypes in the final product. In addition, we show that shifting the CD3/CD28-Dynabeads activation duration from a typical 48 h to 24 h can significantly increase the production of the desired mTCR+CD8+ T cells. Importantly, the percentages of TCR-T cells with less-differentiated phenotypes, namely mTCR central memory T cells (TCM), were found to be preserved with markedly higher efficiency when T cell activation was optimized | ||
520 | |a CONCLUSION: Our findings suggest that the proportion of LDL-R+ T cells may serve as an early assessment parameter for evaluating TCR-T cell quality, possibly facilitating the functional and economical improvement of current adoptive therapy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a CD3/CD28-Dynabeads | |
650 | 4 | |a LDL-R | |
650 | 4 | |a T cell phenotype | |
650 | 4 | |a TCR-T | |
650 | 4 | |a parameter | |
650 | 7 | |a CD3 Complex |2 NLM | |
650 | 7 | |a CD28 Antigens |2 NLM | |
650 | 7 | |a Receptors, Antigen, T-Cell |2 NLM | |
700 | 1 | |a Hao, Ya-Nan |e verfasserin |4 aut | |
700 | 1 | |a Shen, Mei-Ying |e verfasserin |4 aut | |
700 | 1 | |a Han, Xiao-Jian |e verfasserin |4 aut | |
700 | 1 | |a Wang, Ying-Ming |e verfasserin |4 aut | |
700 | 1 | |a Chen, Si-Yin |e verfasserin |4 aut | |
700 | 1 | |a Wang, Jun-Fan |e verfasserin |4 aut | |
700 | 1 | |a Wang, Wang |e verfasserin |4 aut | |
700 | 1 | |a Li, Ting-Ting |e verfasserin |4 aut | |
700 | 1 | |a Jin, Ai-Shun |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t In vivo (Athens, Greece) |d 1992 |g 37(2023), 6 vom: 31. Nov., Seite 2480-2489 |w (DE-627)NLM012776912 |x 1791-7549 |7 nnns |
773 | 1 | 8 | |g volume:37 |g year:2023 |g number:6 |g day:31 |g month:11 |g pages:2480-2489 |
856 | 4 | 0 | |u http://dx.doi.org/10.21873/invivo.13355 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 37 |j 2023 |e 6 |b 31 |c 11 |h 2480-2489 |